
    
      Study subjects will be allocated to either gemigliptin or placebo. After 4 weeks of treatment
      and 2 weeks of wash out period, all subjects will be switched to the opposite arm.

      The subjects will be tested oral fat tolerance test and adipose tissue needle biopsy(only for
      the subjects who agreed to participate donate adipose tissue) at 3 time points: the start of
      1st treatment, end of 1st treatment and end of 2nd treatment.
    
  